Copyright: ©Author(s) 2026.
World J Hepatol. May 27, 2026; 18(5): 116995
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.116995
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.116995
Table 5 Association of IFI16 (rs1057028) with different baseline clinical and laboratory characteristics of hepatitis C virus induced liver fibrosis patients under recessive model
| Measure | IFI16 (rs1057028) recessive model | P value | |
| A/A + A/T (n = 309) | T/T (n = 69) | ||
| Age (years) | 40 (32-50) | 40 (33-45) | 0.87 |
| Gender | |||
| Female | 153 (80.95) | 36 (19.05) | 0.7 |
| Male | 155 (82.45) | 33 (17.55) | |
| BMI (kg/m2) | 26.85 (24-30) | 26.8 (24-30.7) | 0.68 |
| HCV-RNA log10 (IU/mL) | 4.57 (3.7-5.4) | 4.75 (5.4-3.7) | 0.86 |
| ALT (IU/L) | 60 (39-88) | 57 (42-94.5) | 0.69 |
| AST (IU/L) | 56 (40-83) | 51 (38.5-83.5) | 0.63 |
| Bilirubin (mg/dL) | 0.8 (0.7-0.9) | 0.8 (0.7-0.95) | 0.22 |
- Citation: Arshad I, Majid M, Rauff B, Amar A, Choudhery MS. Genetic polymorphism of IFI16 and AIM2 among Pakistani hepatitis C virus-induced fibrosis patients. World J Hepatol 2026; 18(5): 116995
- URL: https://www.wjgnet.com/1948-5182/full/v18/i5/116995.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i5.116995